The Leadership Team at AffyImmune Therapeutics is responsible for setting the strategic direction and vision of the company, guiding its clinical development efforts, and overseeing corporate governance. Comprised of co-founders with deep expertise in biotechnology and oncology, the team focuses on driving innovation in CAR T cell therapies to ensure the advancement of safe and effective treatment solutions for solid tumors.
View all